No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs146009378 |
chr11:65552906-65552907 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs186902066 |
chr11:65552939-65552940 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs499955 |
chr11:65553013-65553014 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
14 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs372912595 |
chr11:65553054-65553055 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
15 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs191194544 |
chr11:65553130-65553131 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription
|
CpG islandChromatin interactive region
|
17 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs563009031 |
chr11:65553233-65553234 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs543523095 |
chr11:65553238-65553239 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs377273236 |
chr11:65553303-65553304 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs36008241 |
chr11:65553306-65553307 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
10 |
rs545148655 |
chr11:65553338-65553339 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs138711529 |
chr11:65553374-65553375 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs116626837 |
chr11:65553423-65553424 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs12287832 |
chr11:65553492-65553493 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
13 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs373160593 |
chr11:65553545-65553546 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs547767785 |
chr11:65553582-65553583 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs561365071 |
chr11:65553601-65553602 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs530029579 |
chr11:65553702-65553703 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs550315741 |
chr11:65553710-65553711 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs570139052 |
chr11:65553724-65553725 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs538841539 |
chr11:65553751-65553752 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs182800185 |
chr11:65553766-65553767 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs565872507 |
chr11:65553810-65553811 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs534964561 |
chr11:65553851-65553852 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs530190416 |
chr11:65553854-65553855 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs116284154 |
chr11:65553864-65553865 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs574388775 |
chr11:65553874-65553875 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs536614769 |
chr11:65553951-65553952 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs76840700 |
chr11:65553954-65553955 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs576487441 |
chr11:65554024-65554025 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs573766130 |
chr11:65554033-65554034 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs565182955 |
chr11:65554075-65554076 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs11227301 |
chr11:65554080-65554081 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
12 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs559684317 |
chr11:65554142-65554143 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs541745515 |
chr11:65554174-65554175 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs561390938 |
chr11:65554259-65554260 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
16 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs530132264 |
chr11:65554313-65554314 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
16 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs550152840 |
chr11:65554370-65554371 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
16 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs71462353 |
chr11:65554463-65554464 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
16 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs563782967 |
chr11:65554499-65554500 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs11227302 |
chr11:65554502-65554503 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs118057726 |
chr11:65554597-65554598 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs61895681 |
chr11:65554611-65554612 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs534483277 |
chr11:65554620-65554621 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs374781811 |
chr11:65554672-65554673 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs10896044 |
chr11:65554680-65554681 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
12 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs568217914 |
chr11:65554689-65554690 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs76185565 |
chr11:65554710-65554711 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs556576940 |
chr11:65554731-65554732 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs570109146 |
chr11:65554741-65554742 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs370761293 |
chr11:65554749-65554750 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|